-
1
-
-
0036220312
-
Electrical, contractile and structural remodeling during atrial fibrillation
-
Allessie M, Ausma J & Schotten U (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54, 230–246.
-
(2002)
Cardiovasc Res
, vol.54
, pp. 230-246
-
-
Allessie, M1
Ausma, J2
Schotten, U3
-
2
-
-
34548692092
-
Down‐regulation of matrix metalloproteinase‐9 (MMP‐9) expression in the myocardium of congestive heart failure patients
-
Batlle M, Perez‐Villa F, Garcia‐Pras E, Lazaro A, Orus J, Roque M & Roig E (2007). Down‐regulation of matrix metalloproteinase‐9 (MMP‐9) expression in the myocardium of congestive heart failure patients. Transplant Proc 39, 2344–2346.
-
(2007)
Transplant Proc
, vol.39
, pp. 2344-2346
-
-
Batlle, M1
Perez‐Villa, F2
Garcia‐Pras, E3
Lazaro, A4
Orus, J5
Roque, M6
Roig, E7
-
3
-
-
0027474009
-
Matrix metalloproteinases: a review
-
Birkedal‐Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal‐Hansen B, DeCarlo A & Engler JA (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4, 197–250.
-
(1993)
Crit Rev Oral Biol Med
, vol.4
, pp. 197-250
-
-
Birkedal‐Hansen, H1
Moore, WG2
Bodden, MK3
Windsor, LJ4
Birkedal‐Hansen, B5
DeCarlo, A6
Engler, JA7
-
4
-
-
0028275578
-
Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone
-
Brilla CG, Zhou G, Matsubara L & Weber KT (1994). Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26, 809–820.
-
(1994)
J Mol Cell Cardiol
, vol.26
, pp. 809-820
-
-
Brilla, CG1
Zhou, G2
Matsubara, L3
Weber, KT4
-
5
-
-
34548169369
-
Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts
-
Brown RD, Jones GM, Laird RE, Hudson P & Long CS (2007). Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem Biophys Res Commun 362, 200–205.
-
(2007)
Biochem Biophys Res Commun
, vol.362
, pp. 200-205
-
-
Brown, RD1
Jones, GM2
Laird, RE3
Hudson, P4
Long, CS5
-
6
-
-
33846429977
-
Angiotensin II increases tissue‐specific inhibitor of metalloproteinase‐2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure‐independent effect
-
Castoldi G, Di Gioia CR, Travaglini C, Busca G, Redaelli S, Bombardi C & Stella A (2007). Angiotensin II increases tissue‐specific inhibitor of metalloproteinase‐2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure‐independent effect. Clin Exp Pharmacol Physiol 34, 205–209.
-
(2007)
Clin Exp Pharmacol Physiol
, vol.34
, pp. 205-209
-
-
Castoldi, G1
Di Gioia, CR2
Travaglini, C3
Busca, G4
Redaelli, S5
Bombardi, C6
Stella, A7
-
7
-
-
33847039932
-
Altered expression of FHL1, CARP, TSC‐22 and P311 provide insights into complex transcriptional regulation in pacing‐induced atrial fibrillation
-
Chen CL, Lin JL, Lai LP, Pan CH, Huang SKS & Lin CS (2007). Altered expression of FHL1, CARP, TSC‐22 and P311 provide insights into complex transcriptional regulation in pacing‐induced atrial fibrillation. Biochim Biophys Acta 1772, 317–329.
-
(2007)
Biochim Biophys Acta
, vol.1772
, pp. 317-329
-
-
Chen, CL1
Lin, JL2
Lai, LP3
Pan, CH4
Huang, SKS5
Lin, CS6
-
8
-
-
7244229584
-
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR‐γ ligand pioglitazone
-
Chen K, Chen J, Li D, Zhang X & Mehta JL (2004). Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR‐γ ligand pioglitazone. Hypertension 44, 655–661.
-
(2004)
Hypertension
, vol.44
, pp. 655-661
-
-
Chen, K1
Chen, J2
Li, D3
Zhang, X4
Mehta, JL5
-
9
-
-
0035050605
-
Angiotensin‐(1–7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells
-
Clark MA, Diz DI & Tallant EA (2001). Angiotensin‐(1–7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension 37, 1141–1146.
-
(2001)
Hypertension
, vol.37
, pp. 1141-1146
-
-
Clark, MA1
Diz, DI2
Tallant, EA3
-
10
-
-
0034887852
-
Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation
-
Coker ML, Jolly JR, Joffs C, Etoh T, Holder JR, Bond BR & Spinale FG (2001). Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am J Physiol Heart Circ Physiol 281, H543–H551.
-
(2001)
Am J Physiol Heart Circ Physiol
, vol.281
, pp. H543-H551
-
-
Coker, ML1
Jolly, JR2
Joffs, C3
Etoh, T4
Holder, JR5
Bond, BR6
Spinale, FG7
-
11
-
-
0032128429
-
Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion
-
Danielsen CC, Wiggers H & Andersen HR (1998). Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol 30, 1431–1442.
-
(1998)
J Mol Cell Cardiol
, vol.30
, pp. 1431-1442
-
-
Danielsen, CC1
Wiggers, H2
Andersen, HR3
-
12
-
-
0027435065
-
Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions
-
Denhardt DT, Feng B, Edwards DR, Cocuzzi ET & Malyankar UM (1993). Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59, 329–341.
-
(1993)
Pharmacol Ther
, vol.59
, pp. 329-341
-
-
Denhardt, DT1
Feng, B2
Edwards, DR3
Cocuzzi, ET4
Malyankar, UM5
-
13
-
-
20444364907
-
Myocardial interstitial matrix metalloproteinase activity is altered by mechanical changes in LV load: interaction with the angiotensin type 1 receptor
-
Deschamps AM, Apple KA, Leonardi AH, McLean JE, Yarbrough WM, Stroud RE, Clark LL, Sample JA & Spinale FG (2005). Myocardial interstitial matrix metalloproteinase activity is altered by mechanical changes in LV load: interaction with the angiotensin type 1 receptor. Circ Res 96, 1110–1118.
-
(2005)
Circ Res
, vol.96
, pp. 1110-1118
-
-
Deschamps, AM1
Apple, KA2
Leonardi, AH3
McLean, JE4
Yarbrough, WM5
Stroud, RE6
Clark, LL7
Sample, JA8
Spinale, FG9
-
14
-
-
18944365126
-
Matrix modulation and heart failure: new concepts question old beliefs
-
Deschamps AM & Spinale FG (2005). Matrix modulation and heart failure: new concepts question old beliefs. Curr Opin Cardiol 20, 211–216.
-
(2005)
Curr Opin Cardiol
, vol.20
, pp. 211-216
-
-
Deschamps, AM1
Spinale, FG2
-
15
-
-
34648843625
-
Mechanisms of cardiac fibrosis in hypertension
-
Diez J (2007). Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens 9, 546–550.
-
(2007)
J Clin Hypertens
, vol.9
, pp. 546-550
-
-
Diez, J1
-
16
-
-
85008120724
-
Biological roles of angiotensin‐(1–7)
-
Ferrario CM (1992). Biological roles of angiotensin‐(1–7). Hypertens Res 15, 61–66.
-
(1992)
Hypertens Res
, vol.15
, pp. 61-66
-
-
Ferrario, CM1
-
17
-
-
0030810845
-
Counterregulatory actions of angiotensin‐(1–7)
-
Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB & Diz DI (1997). Counterregulatory actions of angiotensin‐(1–7). Hypertension 30, 535–541.
-
(1997)
Hypertension
, vol.30
, pp. 535-541
-
-
Ferrario, CM1
Chappell, MC2
Tallant, EA3
Brosnihan, KB4
Diz, DI5
-
18
-
-
33846956137
-
The nonpeptide angiotensin‐(1–7) receptor Mas agonist AVE 0991 attenuates heart failure induced by myocardial infarction
-
Ferreira AJ, Jacoby BA, Araujo CA, Macedo FA, Silva GAB, Almeida AP, Caliari MV & Santos RAS (2007a). The nonpeptide angiotensin‐(1–7) receptor Mas agonist AVE 0991 attenuates heart failure induced by myocardial infarction. Am J Physiol Heart Circ Physiol 292, H1113–H1119.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, pp. H1113-H1119
-
-
Ferreira, AJ1
Jacoby, BA2
Araujo, CA3
Macedo, FA4
Silva, GAB5
Almeida, AP6
Caliari, MV7
Santos, RAS8
-
19
-
-
34548507186
-
Isoproterenol‐induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin‐(1–7) analogue AVE 0991
-
Ferreira AJ, Oliveira TL, Castro MC, Almeida AP, Castro CH, Caliari MV, Gava E, Kitten GT & Santos RAS (2007b). Isoproterenol‐induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin‐(1–7) analogue AVE 0991. Life Sci 81, 916–923.
-
(2007)
Life Sci
, vol.81
, pp. 916-923
-
-
Ferreira, AJ1
Oliveira, TL2
Castro, MC3
Almeida, AP4
Castro, CH5
Caliari, MV6
Gava, E7
Kitten, GT8
Santos, RAS9
-
20
-
-
18944403331
-
Cardiovascular actions of angiotensin‐(1–7)
-
Ferreira AJ & Santos RA (2005). Cardiovascular actions of angiotensin‐(1–7). Braz J Med Biol Res 38, 499–507.
-
(2005)
Braz J Med Biol Res
, vol.38
, pp. 499-507
-
-
Ferreira, AJ1
Santos, RA2
-
21
-
-
0037155057
-
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly
-
Galis ZS & Khatri JJ (2002). Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90, 251–262.
-
(2002)
Circ Res
, vol.90
, pp. 251-262
-
-
Galis, ZS1
Khatri, JJ2
-
22
-
-
33846987938
-
Prevention of angiotensin II‐induced cardiac remodeling by angiotensin‐(1–7)
-
Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK & Katovich M (2007). Prevention of angiotensin II‐induced cardiac remodeling by angiotensin‐(1–7). Am J Physiol Heart Circ Physiol 292, H736–H742.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, pp. H736-H742
-
-
Grobe, JL1
Mecca, AP2
Lingis, M3
Shenoy, V4
Bolton, TA5
Machado, JM6
Speth, RC7
Raizada, MK8
Katovich, M9
-
23
-
-
33744910056
-
Chronic angiotensin‐(1–7) prevents cardiac fibrosis in DOCA‐salt model of hypertension
-
Grobe JL, Mecca AP, Mao H & Katovich MJ (2006). Chronic angiotensin‐(1–7) prevents cardiac fibrosis in DOCA‐salt model of hypertension. Am J Physiol Heart Circ Physiol 290, H2417–H2423.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.290
, pp. H2417-H2423
-
-
Grobe, JL1
Mecca, AP2
Mao, H3
Katovich, MJ4
-
24
-
-
0029978342
-
Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross‐links
-
Gunja‐Smith Z, Morales AR, Romanelli R & Woessner JF Jr (1996). Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross‐links. Am J Pathol 148, 1639–1648.
-
(1996)
Am J Pathol
, vol.148
, pp. 1639-1648
-
-
Gunja‐Smith, Z1
Morales, AR2
Romanelli, R3
Woessner, JF4
-
25
-
-
28144432331
-
Angiotensin‐(1–7) binds to specific receptors on cardiac fibroblasts to initiate anti‐fibrotic and anti‐trophic effects
-
Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX & Greenberg BH (2005). Angiotensin‐(1–7) binds to specific receptors on cardiac fibroblasts to initiate anti‐fibrotic and anti‐trophic effects. Am J Physiol Heart Circ Physiol 289, H2356–H2363.
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
, pp. H2356-H2363
-
-
Iwata, M1
Cowling, RT2
Gurantz, D3
Moore, C4
Zhang, S5
Yuan, JX6
Greenberg, BH7
-
26
-
-
0001751017
-
Differential expression of tissue inhibitors of metalloproteinases in the failing human heart
-
Li YY, Feldman AM, Sun Y & McTiernan CF (1998). Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98, 1728–1734.
-
(1998)
Circulation
, vol.98
, pp. 1728-1734
-
-
Li, YY1
Feldman, AM2
Sun, Y3
McTiernan, CF4
-
27
-
-
34250755564
-
Increased expression of extracellular matrix proteins in rapid atrial pacing‐induced atrial fibrillation
-
Lin CS, Lai LP, Lin JL, Sun YL, Hsu CW, Chen CL, Mao SJT & Huang SKS (2007). Increased expression of extracellular matrix proteins in rapid atrial pacing‐induced atrial fibrillation. Heart Rhythm 4, 938–949.
-
(2007)
Heart Rhythm
, vol.4
, pp. 938-949
-
-
Lin, CS1
Lai, LP2
Lin, JL3
Sun, YL4
Hsu, CW5
Chen, CL6
Mao, SJT7
Huang, SKS8
-
28
-
-
0032534462
-
Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo
-
McEwan PE, Gray GA, Sherry L, Webb DJ & Kenyon CJ (1998). Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 98, 2765–2773.
-
(1998)
Circulation
, vol.98
, pp. 2765-2773
-
-
McEwan, PE1
Gray, GA2
Sherry, L3
Webb, DJ4
Kenyon, CJ5
-
30
-
-
31944445725
-
Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation
-
Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ 3rd, Spinale FG & Gold MR (2006). Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97, 532–537.
-
(2006)
Am J Cardiol
, vol.97
, pp. 532-537
-
-
Mukherjee, R1
Herron, AR2
Lowry, AS3
Stroud, RE4
Stroud, MR5
Wharton, JM6
Ikonomidis, JS7
Crumbley, AJ8
Spinale, FG9
Gold, MR10
-
31
-
-
0028652246
-
Regulation of matrix metalloproteinase activity
-
Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J & Docherty A (1994). Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci 732, 31–41.
-
(1994)
Ann N Y Acad Sci
, vol.732
, pp. 31-41
-
-
Murphy, G1
Willenbrock, F2
Crabbe, T3
O'Shea, M4
Ward, R5
Atkinson, S6
O'Connell, J7
Docherty, A8
-
32
-
-
0033618337
-
Matrix metalloproteinases
-
Nagase H & Woessner JF Jr (1999). Matrix metalloproteinases. J Biol Chem 274, 21491–21494.
-
(1999)
J Biol Chem
, vol.274
, pp. 21491-21494
-
-
Nagase, H1
Woessner, JF2
-
33
-
-
10744229028
-
Matrix metalloproteinase‐9 contributes to human atrial remodeling during atrial fibrillation
-
Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M & Chayama K (2004). Matrix metalloproteinase‐9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 43, 818–825.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 818-825
-
-
Nakano, Y1
Niida, S2
Dote, K3
Takenaka, S4
Hirao, H5
Miura, F6
Ishida, M7
Shingu, T8
Sueda, T9
Yoshizumi, M10
Chayama, K11
-
34
-
-
0030667099
-
Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
-
Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi Y, Shibazaki Y, Iwasaka T & Inada M (1997). Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 96, 3954–3962.
-
(1997)
Circulation
, vol.96
, pp. 3954-3962
-
-
Ohkubo, N1
Matsubara, H2
Nozawa, Y3
Mori, Y4
Murasawa, S5
Kijima, K6
Maruyama, K7
Masaki, H8
Tsutumi, Y9
Shibazaki, Y10
Iwasaka, T11
Inada, M12
-
35
-
-
33846432742
-
Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation
-
Pan CH, Lin JL, Lai LP, Chen CL, Huang SKS & Lin CS (2007). Downregulation of angiotensin converting enzyme II is associated with pacing‐induced sustained atrial fibrillation. FEBS Lett 581, 526–534.
-
(2007)
FEBS Lett
, vol.581
, pp. 526-534
-
-
Pan, CH1
Lin, JL2
Lai, LP3
Chen, CL4
Huang, SKS5
Lin, CS6
-
36
-
-
0034781127
-
Losartan inhibits the angiotensin II‐induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells
-
Papakonstantinou E, Roth M, Kokkas B, Papadopoulos C & Karakiulakis G (2001). Losartan inhibits the angiotensin II‐induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells. J Cardiovasc Pharmacol 38, 715–728.
-
(2001)
J Cardiovasc Pharmacol
, vol.38
, pp. 715-728
-
-
Papakonstantinou, E1
Roth, M2
Kokkas, B3
Papadopoulos, C4
Karakiulakis, G5
-
37
-
-
0036945213
-
Tumor necrosis factor‐α‐induced AT1 receptor upregulation enhances angiotensin II‐mediated cardiac fibroblast responses that favor fibrosis
-
Peng J, Gurantz D, Tran V, Cowling RT & Greenberg BH (2002). Tumor necrosis factor‐α‐induced AT 1 receptor upregulation enhances angiotensin II‐mediated cardiac fibroblast responses that favor fibrosis. Circ Res 91, 1119–1126.
-
(2002)
Circ Res
, vol.91
, pp. 1119-1126
-
-
Peng, J1
Gurantz, D2
Tran, V3
Cowling, RT4
Greenberg, BH5
-
38
-
-
0034032314
-
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat
-
Peterson JT, Li H, Dillon L & Bryant JW (2000). Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46, 307–315.
-
(2000)
Cardiovasc Res
, vol.46
, pp. 307-315
-
-
Peterson, JT1
Li, H2
Dillon, L3
Bryant, JW4
-
39
-
-
0031793775
-
Myocardial angiotensin receptors in human hearts
-
Regitz‐Zagrosek V, Fielitz J & Fleck E (1998). Myocardial angiotensin receptors in human hearts. Basic Res Cardiol 93 (Suppl. 2), 37–42.
-
(1998)
Basic Res Cardiol
, vol.93
, Issue.Suppl. 2
, pp. 37-42
-
-
Regitz‐Zagrosek, V1
Fielitz, J2
Fleck, E3
-
40
-
-
0033735548
-
Angiotensin II induces nuclear factor‐κB activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway
-
Rouet‐Benzineb P, Gontero B, Dreyfus P & Lafuma C (2000). Angiotensin II induces nuclear factor‐κB activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol 32, 1767–1778.
-
(2000)
J Mol Cell Cardiol
, vol.32
, pp. 1767-1778
-
-
Rouet‐Benzineb, P1
Gontero, B2
Dreyfus, P3
Lafuma, C4
-
42
-
-
0037478671
-
Angiotensin‐(1–7) is an endogenous ligand for the G protein‐coupled receptor Mas
-
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, De Buhr I, Heringer‐Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole‐Santos MJ, Schultheiss HP, Speth R & Walther T (2003). Angiotensin‐(1–7) is an endogenous ligand for the G protein‐coupled receptor Mas. Proc Natl Acad Sci USA 100, 8258–8263.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 8258-8263
-
-
Santos, RA1
Simoes e Silva, AC2
Maric, C3
Silva, DM4
Machado, RP5
De Buhr, I6
Heringer‐Walther, S7
Pinheiro, SV8
Lopes, MT9
Bader, M10
Mendes, EP11
Lemos, VS12
Campagnole‐Santos, MJ13
Schultheiss, HP14
Speth, R15
Walther, T16
-
43
-
-
33646161714
-
Impairment of in vitro and in vivo heart function in angiotensin‐(1–7) receptor Mas knockout mice
-
Santos RAS, Castro CH, Gava E, Pinheiro SVB, Almeida AP, Paula RD, Cruz JS, Ramos AS, Rosa KT, Irigoyen MC, Bader M, Alenina N, Kitten GT & Ferreira AJ (2006). Impairment of in vitro and in vivo heart function in angiotensin‐(1–7) receptor Mas knockout mice. Hypertension 47, 996–1002.
-
(2006)
Hypertension
, vol.47
, pp. 996-1002
-
-
Santos, RAS1
Castro, CH2
Gava, E3
Pinheiro, SVB4
Almeida, AP5
Paula, RD6
Cruz, JS7
Ramos, AS8
Rosa, KT9
Irigoyen, MC10
Bader, M11
Alenina, N12
Kitten, GT13
Ferreira, AJ14
-
44
-
-
0036672897
-
Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy
-
Schwartzkopff B, Fassbach M, Pelzer B, Brehm M & Strauer BE (2002). Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Eur J Heart Fail 4, 439–434.
-
(2002)
Eur J Heart Fail
, vol.4
, pp. 439-434
-
-
Schwartzkopff, B1
Fassbach, M2
Pelzer, B3
Brehm, M4
Strauer, BE5
-
45
-
-
7744219599
-
Cell size and communication: role in structural and electrical development and remodeling of the heart
-
Spach MS, Heidlage JF, Barr RC & Dolber PC (2004). Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm 1, 500–515.
-
(2004)
Heart Rhythm
, vol.1
, pp. 500-515
-
-
Spach, MS1
Heidlage, JF2
Barr, RC3
Dolber, PC4
-
46
-
-
0037155784
-
Matrix metalloproteinases: regulation and dysregulation in the failing heart
-
Spinale FG (2002). Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90, 520–530.
-
(2002)
Circ Res
, vol.90
, pp. 520-530
-
-
Spinale, FG1
-
47
-
-
0034680366
-
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
-
Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL & Crumbley AJ (2000). A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 102, 1944–1949.
-
(2000)
Circulation
, vol.102
, pp. 1944-1949
-
-
Spinale, FG1
Coker, ML2
Heung, LJ3
Bond, BR4
Gunasinghe, HR5
Etoh, T6
Goldberg, AT7
Zellner, JL8
Crumbley, AJ9
-
48
-
-
34347405762
-
Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities
-
Stacy LB, Yu Q, Horak K & Larson DF (2007). Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities. Perfusion 22, 51–55.
-
(2007)
Perfusion
, vol.22
, pp. 51-55
-
-
Stacy, LB1
Yu, Q2
Horak, K3
Larson, DF4
-
49
-
-
0035188727
-
How matrix metalloproteinases regulate cell behavior
-
Sternlicht MD & Werb Z (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 463–516.
-
(2001)
Annu Rev Cell Dev Biol
, vol.17
, pp. 463-516
-
-
Sternlicht, MD1
Werb, Z2
-
50
-
-
0028284794
-
Increased angiotensin‐I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction
-
Studer R, Reinecke H, Muller B, Holtz J, Just H & Drexler H (1994). Increased angiotensin‐I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 94, 301–310.
-
(1994)
J Clin Invest
, vol.94
, pp. 301-310
-
-
Studer, R1
Reinecke, H2
Muller, B3
Holtz, J4
Just, H5
Drexler, H6
-
51
-
-
33745066911
-
Angiotensin‐(1–7) inhibits angiotensin II‐stimulated phosphorylation of MAP kinases in proximal tubular cells
-
Su Z, Zimpelmann J & Burns KD (2006). Angiotensin‐(1–7) inhibits angiotensin II‐stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69, 2212–2218.
-
(2006)
Kidney Int
, vol.69
, pp. 2212-2218
-
-
Su, Z1
Zimpelmann, J2
Burns, KD3
-
52
-
-
0141893551
-
Molecular mechanisms of inhibition of vascular growth by angiotensin‐(1–7)
-
Tallant EA & Clark MA (2003). Molecular mechanisms of inhibition of vascular growth by angiotensin‐(1–7). Hypertension 42, 574–579.
-
(2003)
Hypertension
, vol.42
, pp. 574-579
-
-
Tallant, EA1
Clark, MA2
-
53
-
-
0034636783
-
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters
-
Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei K, Matsumoto K, Nakamura T, Higaki J & Ogihara T (2000). Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102, 246–252.
-
(2000)
Circulation
, vol.102
, pp. 246-252
-
-
Taniyama, Y1
Morishita, R2
Nakagami, H3
Moriguchi, A4
Sakonjo, H5
Shokei, K6
Matsumoto, K7
Nakamura, T8
Higaki, J9
Ogihara, T10
-
54
-
-
0032485851
-
Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end‐stage dilated cardiomyopathy
-
Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ 3rd & Spinale FG (1998). Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end‐stage dilated cardiomyopathy. Circulation 97, 1708–1715.
-
(1998)
Circulation
, vol.97
, pp. 1708-1715
-
-
Thomas, CV1
Coker, ML2
Zellner, JL3
Handy, JR4
Crumbley, AJ5
Spinale, FG6
-
55
-
-
0025831950
-
Tissue inhibitor of metalloproteinases‐2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
-
Ward RV, Atkinson SJ, Slocombe PM, Docherty AJ, Reynolds JJ & Murphy G (1991). Tissue inhibitor of metalloproteinases‐2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta 1079, 242–246.
-
(1991)
Biochim Biophys Acta
, vol.1079
, pp. 242-246
-
-
Ward, RV1
Atkinson, SJ2
Slocombe, PM3
Docherty, AJ4
Reynolds, JJ5
Murphy, G6
-
56
-
-
0036940681
-
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure
-
Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee‐Jackson D, Bozkurt B, Deswal A, Mann DL & Spinale FG (2002). Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail 8, 390–398.
-
(2002)
J Card Fail
, vol.8
, pp. 390-398
-
-
Wilson, EM1
Gunasinghe, HR2
Coker, ML3
Sprunger, P4
Lee‐Jackson, D5
Bozkurt, B6
Deswal, A7
Mann, DL8
Spinale, FG9
-
57
-
-
4544281016
-
Differential regulation of matrix metalloproteinase‐2 and ‐9 expression and activity in adult rat cardiac fibroblasts in response to interleukin‐1β
-
Xie Z, Singh M & Singh K (2004). Differential regulation of matrix metalloproteinase‐2 and ‐9 expression and activity in adult rat cardiac fibroblasts in response to interleukin‐1β. J Biol Chem 279, 39513–39519.
-
(2004)
J Biol Chem
, vol.279
, pp. 39513-39519
-
-
Xie, Z1
Singh, M2
Singh, K3
-
58
-
-
13844255016
-
Effects of matrix metalloproteinase‐9 and tissue inhibitor‐1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation
-
Zhu H, Zhang W, Guo CH, Zhang G, Zhang WD, Zhong M, Yang GR, Ge ZM & Zhang Y (2005). Effects of matrix metalloproteinase‐9 and tissue inhibitor‐1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation. [in Chinese]Zhonghua Yi Xue Za Zhi 85, 45–48.
-
(2005)
[in Chinese]Zhonghua Yi Xue Za Zhi
, vol.85
, pp. 45-48
-
-
Zhu, H1
Zhang, W2
Guo, CH3
Zhang, G4
Zhang, WD5
Zhong, M6
Yang, GR7
Ge, ZM8
Zhang, Y9
-
59
-
-
0036872354
-
Angiotensin‐(1–7) inhibits angiotensin II‐induced signal transduction
-
Zhu Z, Zhong J, Zhu S, Liu D, Van Der Giet M & Tepel M (2002). Angiotensin‐(1–7) inhibits angiotensin II‐induced signal transduction. J Cardiovasc Pharmacol 40, 693–700.
-
(2002)
J Cardiovasc Pharmacol
, vol.40
, pp. 693-700
-
-
Zhu, Z1
Zhong, J2
Zhu, S3
Liu, D4
Van Der Giet, M5
Tepel, M6
|